Clinical Trials

Showing trials with last updates posted in 2017.

NCT02662296 | WITHDRAWN | PHASE2
0 participants

Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2017-09-27
Start Date:
2016-03-31
Completion:
2022-02-28
Conditions
  • Prolymphocytic Leukemia
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
Interventions
  • DRUG
No Results Yet
NCT02616692 | COMPLETED
120 participants

HCC Patient Preferences in Japan

Study Type:
OBSERVATIONAL
Last Updated:
2017-09-27
Start Date:
2016-05-09
Completion:
2016-10-07
Conditions
  • Hepatocellular Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page